Long non-coding RNA H19 can predict a poor prognosis and lymph node metastasis: A meta-analysis in human cancer

Minerva Medica

Volumn 107, Issue 4, 2016, Pages 251-258

  Chen, Tao ^a   Yang, Peng ^a   He, Zhen Yu ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

H19 long non coding RNA Lymphatic metastasis; Meta analysis; Prognosis; Survival rate

Indexed keywords

LONG NONCODING RNA H19; LONG UNTRANSLATED RNA; UNCLASSIFIED DRUG; GENETIC MARKER; H19 LONG NON-CODING RNA;

CANCER PROGNOSIS; COLORECTAL CANCER; DISEASE FREE SURVIVAL; GALLBLADDER CARCINOMA; HUMAN; LARYNX SQUAMOUS CELL CARCINOMA; LIVER CELL CARCINOMA; LYMPH NODE METASTASIS; MEDLINE; META ANALYSIS; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; REVIEW; STOMACH CANCER; SURVIVAL RATE; SYSTEMATIC REVIEW; WEB OF SCIENCE; GENE EXPRESSION REGULATION; GENETIC MARKER; GENETICS; NEOPLASM; PROGNOSIS;

GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; HUMANS; LYMPHATIC METASTASIS; NEOPLASMS; PROGNOSIS; RNA, LONG NONCODING;

EID: 84978849135     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Kapusta A, Feschotte C. Volatile evolution of long non-coding RNA repertoires: mechanisms and biological implications. Trends Genet 2014; 30:439-52.
2. Di Gesualdo F., Capaccioli S, Lulli M. A pathophysiological view of the long non-coding RNA world. Oncotarget 2014; 5:10976-96.
3. Malek E, Jagannathan S, Driscoll JJ Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer. Oncotarget 2014; 5:8027-38.
4. Sang H, Liu H, Xiong P., Zhu M. Long non-coding RNA functions in lung cancer. Tumour Biol 2015; 36:4027-37.
5. Martens-Uzunova E.S., Bottcher R, Croce C.M., Jenster G., Visakorpi T, Calin GA. Long noncoding RNA in prostate, bladder, and kidney cancer. Eur Urol 2014; 65:1140-51.
6. Gan L, Xu M, Zhang Y., Zhang X, Guo W. Focusing on long noncoding RNA dysregulation in gastric cancer. Tumour Biol 2015; 36:129-41.
7. Meseure D, DrakAlsibai K, Nicolas A., Bieche I, Morillon A. Long Noncoding RNAs as New Architects in Cancer Epigenetics, Prognostic Biomarkers, and Potential Therapeutic Targets. Biomed Res Int 2015; 2015:320214.
8. Silva A, Bullock M, Calin G. The Clinical Relevance of Long Non-Coding RNAs in Cancer. Cancers (Basel) 2015; 7:2169-82.
9. Tsai MC, Spitale RC, Chang HY Long intergenic non-coding RNAs: new links in cancer progression. Cancer Res 2011; 71:3-7.
10. Steck E, Boeuf S, Gabler J., Werth N, Schnatzer P, Diederichs S., et al. Regulation of H19 and its encoded microRNA-675 in osteoarthritis and under anabolic and catabolic in vitro conditions. J Mol Med (Berl) 2012; 90:1185-95.
11. Chen JS, Wang YF, Zhang X.Q., Lv JM, Li Y, Liu XX, et al H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer. Neoplasma 2016; 63:223-30.
12. Han D, Gao X, Wang M., Qiao Y, Xu Y, Yang J., et al. Long noncoding RNA H19 indicates a poor prognosis of colorectal cancer and promotes tumor growth by recruiting and binding to eIF4A3. Oncotarget 2016 Mar 14. [Epub ahead of print]
13. Zhang E, Li W, Yin D., De W, Zhu L, Sun S., et al. c-Mycregulated long non-coding RNA H19 indicates a poor prognosis and affects cell proliferation in non-small-cell lung cancer. Tumour Biol 2016; 37:4007-15.
14. Zhang EB, Han L, Yin D.D., Kong R., De W, Chen J. cMyc-induced, long, noncoding H19 affects cell proliferation and predicts a poor prognosis in patients with gastric cancer. Med Oncol 2014; 31:914.
15. Chen B, Yu M, Chang Q., Lu Y, Thakur C, Ma D., et al. Mdig de-represses H19 large intergenic non-coding RNA (lincRNA) by down-regulating H3K9me3 and heterochromatin. Oncotarget 2013; 4:1427-37.
16. Li H, Yu B, Li J., Su L, Yan M, Zhu Z., et al. Overexpression of IncRNA H19 enhances carcinogenesis and metastasis of gastric cancer. Oncotarget 2014; 5:2318-29.
17. Wang SH, Wu XC, Zhang M.D., Weng MZ, Zhou D, Quan ZW. Upregulation of H19 indicates a poor prognosis in gallbladder carcinoma and promotes epithelial-mesenchymal transition. Am J Cancer Res 2016; 6:15-26.
18. Wang SH, Wu XC, Zhang M.D., Weng MZ, Zhou D, Quan ZW. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2. Tumour Biol 2016 Jan 23. [Epub ahead of print]
19. Wu T, Qu L, He G., Tian L, Li L, Zhou H., et al. Regulation of laryngeal squamous cell cancer progression by the IncRNA H19/miR-148a-3p/DNMTl axis. Oncotarget 2016; 7:11553-66.
20. Yang Z, Lu Y, Xu Q., Tang B, Park CK, Chen X. HULC and H19 Played Different Roles in Overall and Disease-Free Survival from Hepatocellular Carcinoma after Curative Hepatectomy: A Preliminary Analysis from Gene Expression Omnibus. Dis Markers 2015; 2015:191029.
21. Matouk I, Raveh E, Ohana P., Lail RA, Gershtain E, Gilon M, et al The increasing complexity of the oncofetal h19 gene locus: functional dissection and therapeutic intervention. Int J Mol Sci 2013; 14:4298-316.
22. Matouk IJ, Raveh E, Abu-lail R, Mezan S., Gilon M, Gershtain E, et al Oncofetal H19 RNA promotes tumor metastasis. Biochim Biophys Acta 2014; 1843:1414-26.
23. Tierney JF, Stewart LA, Ghersi D, Burdett S., Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007; 8:16.
24. Higgins JP, Thompson SG Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21:1539-58.
25. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-88.
26. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629-34.
27. Shi X, Sun M, Liu H., Yao Y, Song Y Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett 2013; 339:159-66.
28. Zhang S, Chen S, Yang G., Gu F, Li M, Zhong B., et al. Long Noncoding RNA HOTAIR as an Independent Prognostic Marker in Cancer: A Meta-Analysis. PLOS ONE 2014; 9:e105538.
29. Zhu L, Liu J, Ma S., Zhang S. Long Noncoding RNA MALAT-1 Can Predict Metastasis and a Poor Prognosis: a Meta-Analysis. Pathol Oncol Res 2015; 21:1259-64.
30. Cai X, Cullen BR The imprinted H19 noncoding RNAis a primary microRNA precursor. RNA 2007; 13:313-6.
31. Matouk IJ, Mezan S, Mizrahi A., Ohana P, Abu-Lail R, Fellig Y, et al The oncofetal H19 RNA connection: hypoxia, p53 and cancer. Biochim Biophys Acta 2010; 1803:443-51.
32. Yang F, Bi J, Xue X., Zheng L, Zhi K, Hua J., et al. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS J 2012; 279:3159-65.
33. Keniry A, Oxley D, Monnier P., Kyba M, Dandolo L, Smits G., et al. The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igflr. Nat Cell Biol 2012; 14:659-65.
34. Zhuang M, Gao W, Xu J., Wang P, Shu Y The long non-coding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1. Biochem Biophys Res Commun 2014; 448:315-22.
35. Vennin C, Sprayt N, Dahmani F., Julien S, Bertucci F, Finetti P., et al. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b. Oncotarget 2015; 6:29209-23.
36. Yu LL, Chang K, Lu L.S., Zhao D., Han J, Zheng YR, et al Lentivirus-mediated RNA interference targeting the H19 gene inhibits cell proliferation and apoptosis in human choriocarcinoma cell line JAR. BMC Cell Biol 2013; 14:26.